Article
The case of T-ALL presenting with NK phenotype after COVID-19 vaccination.
Pathology, research and practice - 1 Feb 2023
Yanagida Eriko, Kubota Akira, Miyoshi Hiroaki, Ohshima Koichi, Kawakita Toshiro, Murayama Toshihiko
Abstract excerpt
NK-lymphoblastic leukemia/lymphoma (NK-LL) is an extremely rare hematopoietic tumor consisting of natural killer (NK) precursor cells, and their lineage overlaps with T-cells, making it challenging to diagnose. COVID-19 vaccination is recommended for people with a risk of aggravation such as cancer-bearing patients, including hematopoietic tumors. We present a 55-year-old man who had cervical lymph node swelling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
